Open trial of topical tacalcitol [1α24(OH)2D3] and solar irradiation for vitiligo vulgaris: Upregulation of c-Kit mRNA by cultured melanocytes

European Journal of Dermatology

Volumn 13, Issue 4, 2003, Pages 372-376

  Katayama, Ichiro ^a   Ashida, Miwa ^a   Maeda, Aki ^a   Eishi, Kumiko ^a   Murota, Hiroyuki ^a   Bae, Sang Jae ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

1 24(OH)2D3 solar irradiation; c Kit; Tacalcitol; Vitamin D3; Vitiligo

Indexed keywords

CORTICOSTEROID; MESSENGER RNA; STEM CELL FACTOR; TACALCITOL;

ADULT; AGED; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DRUG MECHANISM; DRUG RESPONSE; FEMALE; GENE CONTROL; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MELANOCYTE; OINTMENT; OPEN STUDY; PUVA; SCHOOL CHILD; SOLAR RADIATION; SUNBURN; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; UPREGULATION; VITILIGO; VITILIGO VULGARIS;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; CELLS, CULTURED; CHILD; DERMATOLOGIC AGENTS; DIHYDROXYCHOLECALCIFEROLS; EYELIDS; FEMALE; HUMANS; MALE; MELANOCYTES; MIDDLE AGED; OINTMENTS; PROTO-ONCOGENE PROTEINS C-KIT; RNA, MESSENGER; SUNLIGHT; TREATMENT OUTCOME; UP-REGULATION; VITILIGO;

EID: 0042160176     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Njoo MD, Westerhof W, Bos JD et al. The development of guidelines for the treatment of vitiligo. ClinicalEpidemiology Unit of the Instituto Dermopatico dell'Immacolata-Instituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology. Arch Dermatol 1999; 135: 1514-21.
2. van Geel N, Ongenae K, Naeyaert JM. Surgical techniques for vitiligo: a review. Dermatology 2001; 202: 162-6.
3. Fukuoka M, Sakurai K, Ohta T et al. Tacalcitol, an octive vitamin D(3), induces nerve growth factor production in human epidermal keratinocytes. Skin Pharmacol Appl Skin Physiol 2001; 14: 226-33.
4. Vandenbark GR, deCastro CM, Taylor H et al. Cloning and structural analysis of the human c-kit gene. Oncogene 1992; 7: 1259-66.
5. Yalcin B, Sahin S, Bukulmez G et al. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study. J Am Acad Dermatol 2001; 44: 634-7.
6. Parsad D, Saini R, Nagpal R. Calcipotriol in vitiligo: a preliminary study. Pediatr Dermatol 1999; 16: 317-20.
7. Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology 1998; 197: 167-70.
8. Norris A, Todd C, Graham A et al. The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo. Br J Dermatol 1996; 134: 299-306.
9. Ito M, Kawa Y, Ono H et al. Removal of stem cell factor or addition of monoclonal anti-c-Kit antibody induces apoptosis in murine melanocyte precursors. J Invest Dermatol 1999; 112: 796-801.
10. Imokawa G, Kobayasi T, Miyagishi M. Intracellular signaling mechanisms leading to synergistic effects of endothelin-1 and stem cell factor on proliferation of cultured human melanocytes. Cross-talk via trans-activation of the tyrosine kinase c-Kit receptor. J Biol Chem 2000; 275: 33321-8.
11. Hu DN, M C Cormick SA, Woodward DF. A functional study on prostanoid receptors involved in cultured human iridal melanocyte stimulation. Exp Eye Res 2001; 73: 93-100.
12. Tomita Y, Maeda K, Tagami H. Histamine stimulates normal human melanocytes in vitro: one of the possible inducers of hyperpigmentation in urticaria pigmentosa. J Dermatol Sci 1993; 6: 146-54.
13. Halaban R. The regulation of normal melanocyte proliferation. Pigment Cell Res 2000; 13: 4-14.
14. Lemire JM, Adams JS, Kermani-Arab V et al. 1,25 hydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 1985; 134: 3032-5.
15. Piemonti L, Monti P, Sironi M et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000; 164: 4443-51.
16. Yee C, Thompson JA, Roche P et al. Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J Exp Med 2000; 192: 1637-44.
17. Fukuoka M, Ogino Y, Sato H et al. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Br J Dermatol 1998; 138: 63-70.
18. Scherschun L, Kim JJ, Lim HW. Narrow -band ultraviolet B is a useful and well-tolerated treatment for vitiligo. Arch Dermatol 2001; 44: 999-1003.
19. Ermis O, Alpsoy E, Cetin L, Yilmaz E. Is the efficacy of psorolen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br J Dermatol 2001; 145: 472-5.
20. Lebwohl M, Hecker D, Martinez J et al. Interactions between calcipotoriol and ultraviolet light. J Am Acad Derm 1997; 37: 93-5.